Differential Prognostic Impact of Clinical Congestion between Preserved versus Reduced Ejection Fraction in Patients Hospitalized for Acute Decompensated Heart Failure: Findings from the Japanese KCHF registry.

acutely decompensated heart failure clinical congestion left ventricular ejection fraction prognosis

Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 14 01 2024
revised: 26 08 2024
accepted: 28 08 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 2 10 2024
Statut: aheadofprint

Résumé

Most patients hospitalized for heart failure (HF) present with signs of congestion. Prognostic significance of clinical congestion may vary depending on left ventricular ejection fraction (LVEF). This study aims to investigate the prognostic impact of congestion across different LVEF categories. Composite congestion scores (CCS) (0-9) derived from the severity of edema, jugular venous pressure, and orthopnea, were analyzed on admission and at discharge in 3787 patients hospitalized for HF (LVEF≥40%: n=2347, LVEF<40%: n=1440). The median admission CCS was 4 in both LVEF strata (P=0.64). Adjusted HRs (95%CI) of the moderate [CCS 4-6] and severe congestion [7-9] groups relative to the mild congestion [0-3] group on admission for a composite of all-cause death or HF re-hospitalization were 1.20 (1.04-1.39, P=0.01) and 1.54 (1.27-1.86, P<0.001) in the LVEF≥40% stratum, and 1.20 (1.01-1.44, P=0.04) and 0.82 (0.61-1.07, P=0.14) in the LVEF<40% stratum, respectively (P The severity of clinical congestion on admission was associated with adverse clinical outcomes in patients with LVEF ≥40%, but no in those with LVEF <40%. These findings warrant further studies to better understand the detailed profile of congestion across the LVEF spectrum.

Sections du résumé

BACKGROUNDS BACKGROUND
Most patients hospitalized for heart failure (HF) present with signs of congestion. Prognostic significance of clinical congestion may vary depending on left ventricular ejection fraction (LVEF). This study aims to investigate the prognostic impact of congestion across different LVEF categories.
METHODS AND RESULTS RESULTS
Composite congestion scores (CCS) (0-9) derived from the severity of edema, jugular venous pressure, and orthopnea, were analyzed on admission and at discharge in 3787 patients hospitalized for HF (LVEF≥40%: n=2347, LVEF<40%: n=1440). The median admission CCS was 4 in both LVEF strata (P=0.64). Adjusted HRs (95%CI) of the moderate [CCS 4-6] and severe congestion [7-9] groups relative to the mild congestion [0-3] group on admission for a composite of all-cause death or HF re-hospitalization were 1.20 (1.04-1.39, P=0.01) and 1.54 (1.27-1.86, P<0.001) in the LVEF≥40% stratum, and 1.20 (1.01-1.44, P=0.04) and 0.82 (0.61-1.07, P=0.14) in the LVEF<40% stratum, respectively (P
CONCLUSION CONCLUSIONS
The severity of clinical congestion on admission was associated with adverse clinical outcomes in patients with LVEF ≥40%, but no in those with LVEF <40%. These findings warrant further studies to better understand the detailed profile of congestion across the LVEF spectrum.

Identifiants

pubmed: 39357667
pii: S1071-9164(24)00413-5
doi: 10.1016/j.cardfail.2024.08.060
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Kazuya Nagao (K)

Cardiovascular center, Osaka Red Cross Hospital, Osaka, Japan.

Takao Kato (T)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: tkato75@kuhp.kyoto-u.ac.jp.

Hidenori Yaku (H)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takeshi Morimoto (T)

Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan.

Kenji Aida (K)

Cardiovascular center, Osaka Red Cross Hospital, Osaka, Japan.

Shiori Kawakami Maruichi (SK)

Cardiovascular center, Osaka Red Cross Hospital, Osaka, Japan.

Yasutaka Inuzuka (Y)

Department of Cardiovascular Medicine, Shiga Medical Center for Adult, Shiga, Japan.

Yodo Tamaki (Y)

Division of Cardiology, Tenri Hospital, Nara, Japan.

Erika Yamamoto (E)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yusuke Yoshikawa (Y)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takeshi Kitai (T)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Hyogo, Japan.

Ryoji Taniguchi (R)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.

Moritake Iguchi (M)

National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Masashi Kato (M)

Mitsubishi Kyoto Hospital, Kyoto, Japan.

Mamoru Takahashi (M)

Shimabara Hospital, Kyoto, Japan.

Toshikazu Jinnai (T)

Japanese Red Cross Otsu Hospital, Shiga, Japan.

Takafumi Kawai (T)

Kishiwada City Hospital, Osaka, Japan.

Akihiro Komasa (A)

Kansai Electric Power Hospital, Osaka, Japan.

Ryusuke Nishikawa (R)

Shizuoka General Hospital, Shizuoka, Japan.

Yuichi Kawase (Y)

Kurashiki Central Hospital, Okayama, Japan.

Takashi Morinaga (T)

Kokura Memorial Hospital, Fukuoka, Japan.

Kanae Su (K)

Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

Mitsunori Kawato (M)

Nishikobe Medical Center, Hyogo, Japan.

Yuta Seko (Y)

Kitano Hospital, Osaka, Japan.

Tsukasa Inada (T)

Cardiovascular center, Osaka Red Cross Hospital, Osaka, Japan.

Moriaki Inoko (M)

Kitano Hospital, Osaka, Japan.

Mamoru Toyofuku (M)

Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

Yutaka Furukawa (Y)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Hyogo, Japan.

Yoshihisa Nakagawa (Y)

Division of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.

Kenji Ando (K)

Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

Kazushige Kadota (K)

Kokura Memorial Hospital, Fukuoka, Japan.

Satoshi Shizuta (S)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yukihito Sato (Y)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.

Koichiro Kuwahara (K)

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine, Matsumoto, Japan.

Neiko Ozasa (N)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Koh Ono (K)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takeshi Kimura (T)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Classifications MeSH